March 20th, 2018
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Cancer
September 15th, 2016
A taste for fat
Scientists at Harvard Medical School discover molecular handle behind some cancers’ preference for fat
September 28th, 2015
Attacking acute myeloid leukemia
A molecule isolated from sea sponges and synthesized at Harvard can halt the growth of cancerous cells.
